Events
QB3 “4×4” Bio VC Pitch Session April 2026


In a reprise of our successful event from September 2025, four biotech startup founders participating in QB3’s early-stage programs will pitch four VCs actively investing in this area. Join us to learn from the live critique and network with current and future entrepreneurs in UC Berkeley’s vibrant ecosystem.
VCs taking part: Gary Yeung (YK Bioventures), Ameena El-Bibany (seed investor formerly at ARTIS and Rising Tide), Philipp Sander (SOSV/IndieBio), Nicole Sonnert (Playground Global).
Companies pitching: Dohrnii, Eyebiome, Inixi Bio, Tendril Scientific.
- EyeBiome is developing a modular living-therapeutics platform for dry eye disease.
- Dohrnii is targeting aggregation-linked diseases including Huntington’s.
- Inixi Bio is developing a new class of tumor-agnostic initiation inhibitors.
- Tendril Scientific combines large-scale functional assays in plant cells with AI-driven protein design to discover superior crop plants.
Photos from September 2025 4×4 event






